Ping-Chih Hsu - Search Results

Year	Number of Results
2014	1
2015	1
2016	2
2017	6
2018	5
2019	5
2020	7
2021	9
2022	17
2023	10

1

Epidermal Growth Factor Receptor (EGFR) Pathway, Yes-Associated Protein (YAP) and the Regulation of Programmed Death-Ligand 1 (PD-L1) in Non-Small Cell Lung Cancer (NSCLC).

Hsu PC, Jablons DM, Yang CT, You L. Hsu PC, et al. Int J Mol Sci. 2019 Aug 5;20(15):3821. doi: 10.3390/ijms20153821. Int J Mol Sci. 2019. PMID: 31387256 Free PMC article. Review.

2

Immunotherapy and Vaccination in Surgically Resectable Non-Small Cell Lung Cancer (NSCLC).

Chiu LC, Lin SM, Lo YL, Kuo SC, Yang CT, Hsu PC. Chiu LC, et al. Among authors: hsu pc. Vaccines (Basel). 2021 Jun 23;9(7):689. doi: 10.3390/vaccines9070689. Vaccines (Basel). 2021. PMID: 34201650 Free PMC article. Review.

3

The Crosstalk between Src and Hippo/YAP Signaling Pathways in Non-Small Cell Lung Cancer (NSCLC).

Hsu PC, Yang CT, Jablons DM, You L. Hsu PC, et al. Cancers (Basel). 2020 May 26;12(6):1361. doi: 10.3390/cancers12061361. Cancers (Basel). 2020. PMID: 32466572 Free PMC article. Review.

4

The Role of Yes-Associated Protein (YAP) in Regulating Programmed Death-Ligand 1 (PD-L1) in Thoracic Cancer.

Hsu PC, Yang CT, Jablons DM, You L. Hsu PC, et al. Biomedicines. 2018 Dec 7;6(4):114. doi: 10.3390/biomedicines6040114. Biomedicines. 2018. PMID: 30544524 Free PMC article. Review.

5

Sequential treatment in advanced non-small cell lung cancer harboring EGFR mutations.

Hsu PC, Chang JW, Chang CF, Huang CY, Yang CT, Kuo CS, Fang YF, Wu CE. Hsu PC, et al. Ther Adv Respir Dis. 2022 Jan-Dec;16:17534666221132731. doi: 10.1177/17534666221132731. Ther Adv Respir Dis. 2022. PMID: 36305280 Free PMC article.

6

Targeting YAP in malignant pleural mesothelioma.

Zhang WQ, Dai YY, Hsu PC, Wang H, Cheng L, Yang YL, Wang YC, Xu ZD, Liu S, Chan G, Hu B, Li H, Jablons DM, You L. Zhang WQ, et al. Among authors: hsu pc. J Cell Mol Med. 2017 Nov;21(11):2663-2676. doi: 10.1111/jcmm.13182. Epub 2017 May 4. J Cell Mol Med. 2017. PMID: 28470935 Free PMC article.

7

Impaired interferon-α expression in plasmacytoid dendritic cells in asthma.

Lin TY, Lo CY, Tsao KC, Chang PJ, Kuo CS, Lo YL, Lin SM, Hsieh MH, Wang TY, Hsu PC, Lin HC. Lin TY, et al. Among authors: hsu pc. Immun Inflamm Dis. 2021 Mar;9(1):183-195. doi: 10.1002/iid3.376. Epub 2020 Nov 25. Immun Inflamm Dis. 2021. PMID: 33236850 Free PMC article.

8

Real-world Afatinib Outcomes in Advanced Non-small Cell Lung Cancer Harboring EGFR Mutations.

Chen CH, Chang JW, Chang CF, Huang CY, Yang CT, Kuo CS, Fang YF, Hsu PC, Wu CE. Chen CH, et al. Among authors: hsu pc. Anticancer Res. 2022 Apr;42(4):2145-2157. doi: 10.21873/anticanres.15697. Anticancer Res. 2022. PMID: 35347039

9

The cancer stemness inhibitor napabucasin suppresses small cell lung cancer growth through SOX2 expression.

Li JM, Hsu PC, Kuan FC, Shi CS, Yang CT. Li JM, et al. Among authors: hsu pc. Am J Cancer Res. 2022 Oct 15;12(10):4637-4651. eCollection 2022. Am J Cancer Res. 2022. PMID: 36381330 Free PMC article.

10

Comprehensive assessment of pretreatment sarcopenia impacts on patients with EGFR-mutated NSCLC treated with afatinib.

Wu CT, Hsu PC, Chang JW, Chang CF, Huang CY, Yang CT, Kuo CS, Fang YF, Wu CE. Wu CT, et al. Among authors: hsu pc. Thorac Cancer. 2023 Sep;14(25):2548-2557. doi: 10.1111/1759-7714.15017. Epub 2023 Jul 31. Thorac Cancer. 2023. PMID: 37525557 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

56 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

56 results

Results by year